Director, Mass Spectrometry Imaging Facility
MD Anderson Cancer Center
Houston, Texas
Dr. Seeley is the Director of the Mass Spectrometry Imaging Facility at MD Anderson Cancer Center. She has over 25 years of experience in mass spectrometry and analytical techniques. She completed her Ph.D. at Purdue University under the direction of Dr. Fred Regnier studying comparative proteomic analyses with a focus on phosphoproteomics.
She spent a combined 9 years in the laboratory of Dr. Richard Caprioli (the inventor of MALDI MSI) as a Postdoc and then Associate Director of the Vanderbilt University Tissue Imaging Core, where she worked with a wide variety of sample types and analyte targets in clinical and preclinical imaging studies. During this time, she developed and streamlined a histology-guided MS profiling workflow for high throughput analysis of clinical samples for diagnostic and prognostic applications. After leaving Vanderbilt, she worked for 6 years in a CRO setting offering MSI services.
In 2020, she established the CPRIT funded Mass Spectrometry Imaging Core at the Unversity of Texas at Austin, which she directed for 5.5 years. In August 2025, she moved to MD Anderson to start a new MSI core.
Over her career, her main focus has been on clinical applications of mass spectrometry imaging for improving diagnostics and prognostics.
Disclosure information not submitted.
Tuesday, November 11, 2025
9:30 AM - 10:00 AM CT